Product correctly added to cart.

discount label
EGFR-IN-7
View 3D

Biosynth logo

EGFR-IN-7

CAS: 2267329-76-8

Ref. 3D-SQD32976

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 12 Feb 2025

Product Information

Name:
EGFR-IN-7
Description:

EGFR-IN-7 is a mutant of epidermal growth factor receptor (EGFR) that has been shown to be resistant to EGFR tyrosine kinase inhibitors. EGFR-IN-7 has been shown to bind to ubiquitin and inhibit ubiquitin ligases, which are enzymes that regulate the degradation of proteins. This inhibition leads to increased levels of the EGFR protein, resulting in an increase in the frequency of cells with an activated EGFR receptor. The accumulation of these cells may lead to tumor formation if left unchecked. It has also been shown that this mutant binds to other receptors on the cell surface, such as Factor Receptor, thereby increasing its potential for cellular transformation. EGFR-IN-7 has proven effective at inhibiting proliferation in cancer cells.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
694.6 g/mol
Formula:
C32H41BrN9O2P
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-SQD32976 EGFR-IN-7

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".